CIBC Private Wealth Group
NVNO

CIBC Private Wealth Group’s enVVeno Medical NVNO Stock Holding History

CIBC Private Wealth Group’s Portfolio NVNO Stock Details NVNO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$276 Hold
25
– – ﹤0.01% 3157
2025
Q3 		$779 Hold
25
– – ﹤0.01% 2841
2025
Q2 		$3.43K Hold
25
– – ﹤0.01% 2534
2025
Q1 		$1.82K Hold
25
– – ﹤0.01% 2705
2024
Q4 		$2.89K Hold
25
– – ﹤0.01% 2624
2024
Q3 		$2.89K Hold
25
– – ﹤0.01% 2739
2024
Q2 		$4.28K Hold
25
– – ﹤0.01% 2556
2024
Q1 		$4.53K Buy
+25
New +$4.49K ﹤0.01% 2535

Other funds holding NVNO

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

CIBC Private Wealth Group's NVNO Position: Q4 2025 in Review

CIBC Private Wealth Group held its enVVeno Medical (NVNO) position steady in Q4 2025 at 25 shares worth $276. The position accounts for ﹤0.01% of the portfolio, ranked #3157.

CIBC Private Wealth Group first reported a position in NVNO in Q1 2024 and has held it in 8 quarters since. The position peaked at $4.53K in Q1 2024. 36 funds tracked by Wall St. Rank hold NVNO as of Q4 2025.

  • CIBC Private Wealth Group held 25 shares of enVVeno Medical worth $276 as of Q4 2025.
  • CIBC Private Wealth Group left its enVVeno Medical share count unchanged in Q4 2025.
  • enVVeno Medical made up ﹤0.01% of CIBC Private Wealth Group's portfolio in Q4 2025, its #3157 holding.
  • CIBC Private Wealth Group first reported a position in enVVeno Medical in Q1 2024 and has held it in 8 quarters since.
  • CIBC Private Wealth Group's enVVeno Medical position peaked at $4.53K in Q1 2024.
  • 36 funds tracked by Wall St. Rank held enVVeno Medical as of Q4 2025.

Based on CIBC Private Wealth Group's 13F filing for Q4 2025, filed 12 Feb 2026.